Gastric cancer and concomitant renal cancer: A systematic immunohistochemical and molecular analysis

Oncology Reports

Volumn 26, Issue 3, 2011, Pages 567-575

  Betge, Johannes ^a   Pollheimer, Marion J ^a   Schlemmer, Andrea ^a   Hoefler, Gerald ^a   Langner, Cord ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Epstein Barr virus; Hereditary neoplasms; In situ hybridization; KRAS; Microsatellite instability; Multiple primary neoplasms

Indexed keywords

K RAS PROTEIN; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN P53; UVOMORULIN; VIRUS RNA;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; CODON; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; MISMATCH REPAIR; MOLECULAR DYNAMICS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYROSEQUENCING; STOMACH CANCER;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, RENAL CELL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RNA, VIRAL; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79959987759     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1346     Document Type: Article

References (62)

1. Boyle P and Levin B (eds): World Health Organization. World Cancer Report. IARC Press, Lyon, 2008.
2. Carneiro F, Oliveira C, Leite M and Seruca R: Molecular targets and biological modifiers in gastric cancer. Semin Diagn Pathol 25: 274-287, 2008.
3. Humar B and Guilford P: Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci 100: 1151-1157, 2009.
4. Oliveira C, Seruca R and Carneiro F: Hereditary gastric cancer. Best Pract Res Clin Gastroenterol 23: 147-157, 2009.
5. Friedenson B: BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian. MedGenMed 7: 60, 2005.
6. Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P and Eeles RA: Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 63: 6643-6650, 2003. (Pubitemid 37322942)
7. Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF and Boland CR: Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76: 1-18, 2009.
8. Aaltonen LA, Peltomäki P, Mecklin JP, et al: Replication errors in benign and malignant tumors from hereditary non-polyposis colorectal cancer patients. Cancer Res 54: 1645-1648, 1994. (Pubitemid 24116162)
9. Matsutani T, Sasajima K, Miyamoto M, et al: Resection of pancreatic metastasis from renal cell carcinoma and an early gastric cancer. J Nippon Med Sch 75: 41-45, 2008. (Pubitemid 351303858)
10. Roh JH, Kim HJ, Jang KT, Kim KM, Kim JJ, Kim S and Park CK: Metastatic renal cell carcinoma masquerading as a primary gastric carcinoma associated with synchronous early gastric carcinoma. Pathology 40: 83-85, 2008. (Pubitemid 350172956)
11. Valle L, Cascón A, Melchor L, et al: About the origin and development of hereditary conventional renal cell carcinoma in a four-generation t(3;8)(p141;q2423) family. Eur J Hum Genet 13: 570-578, 2005. (Pubitemid 40691397)
12. Kobayashi S, Kabuto T, Doki Y, et al: Synchronous esophageal and renal cell carcinoma. Dis Esophagus 13: 305-310, 2000. (Pubitemid 32396524)
13. Mukai M, Makuuchi H, Mukohyama S, et al: Quintuple carcinomas with metachronous triple cancer of the esophagus, kidney, and colonic conduit following synchronous double cancer of the stomach and duodenum. Oncol Rep 8: 111-114, 2001. (Pubitemid 33758211)
14. Piccinini L, Luppi G, Zoboli A and Torricelli P: Occasional diagnosis of synchronous renal cell carcinoma during staging of other primary tumors. Tumori 82: 488-490, 1996. (Pubitemid 27013335)
15. Casetta G, Piana P, Gamba P, Gontero P, Bodo G, Lauro D and Calderini P: Appearance in 2 brothers of double primary neoplasms: right renal carcinoma and gastric adenocarcinoma. Minerva Urol Nefrol 47: 49-51, 1995.
16. Murakami S, Yashuda S, Nakamura T, Mishima Y, Iida H, Okano H and Nakano M: A case of renal cell carcinoma with metastasis to the thyroid gland and concomitant early gastric cancer. Surg Today 23: 153-158, 1993. (Pubitemid 23030597)
17. Nagral A, Mohandas KM, Swaroop D, et al: Double primary neoplasms of the stomach and kidney. Indian J Gastroenterol 10: 67-68, 1991.
18. Azuma T, Koide A, Asami H, et al: A case of synchronous multiple primary cancers of the stomach and kidney. Gan No Rinsho 36: 2605-2609, 1990.
19. Kamiya T, Ooshita H, Kubota M, et al: A case of triple carcinomas: stomach carcinoma surgically removed, renal tumor, and carcinoma of the remnant stomach. Gan No Rinsho 36: 2193-2199, 1990.
20. Funaki H, Suzuki N, Adachi M, et al: Double primary malignant neoplasm of renal cell carcinoma and stomach cancer: report of two cases. Hinyokika Kiyo 31: 1629-1634, 1985. (Pubitemid 15231202)
21. Yoshizumi Y, Shima S, Sugiura Y, Yonekawa H, Ogata T, Nagakura K and Aikawa A: A case of simultaneous surgery for primary double cancer of the stomach and kidney. Gan No Rinsho 31: 429-433, 1985.
22. Tashiro K, Kondo N, Ueda M, et al: A case study with bladder metastasis of renal cell carcinoma and stomach cancer. Hinyokika Kiyo 30: 249-252, 1984.
23. StatistikAustria. Magen(C16)-Krebsinzidenz(Neuerkrankungen pro Jahr), Österreich ab 1983 [document on the internet]. Vienna: Bundesanstalt Statistik Österreich; 2009, cited 2011-02-10. Available from: URL:http://www.statistikat/web-de/statistiken/gesundheit/krebserkrankungen/ magen/021771.html.
24. Pollheimer MJ, Hinterleitner TA, Pollheimer VS, Schlemmer A and Langner C: Renal cell carcinoma metastatic to the stomach: single-centre experience and literature review. BJU Int 102: 315-319, 2008. (Pubitemid 352019194)
25. Sobin LH, Gospodarowicz MK and Wittekind C (eds): UICC International Union Against Cancer: TNM Classification of Malignant Tumors, 2009. 7th edition. John Riley and Sons Ltd., West Sussex, 2010.
26. Eble JN, Sauter G, Epstein JI and Sesterhenn IA (eds): World Health Organization: Classification of Tumors. Pathology and Genetics - Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon, 2004.
27. World Health Organization: Classification of Tumors. Pathology and Genetics - Tumours of the Digestive System. IARC Press, Lyon, 2000.
28. Laurén P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-49, 1965.
29. Rahner N and Steinke V: Hereditary cancer syndromes. Dtsch Arztebl Int 105: 706-714, 2008.
30. Smyrk TC, Watson P, Kaul K and Lynch HT: Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer 91: 2417-2422, 2001. (Pubitemid 32552830)
31. Grogg KL, Lohse CM, Pankratz VS, Hailing KC and Smyrk TC: Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival. Mod Pathol 16: 641-651, 2003. (Pubitemid 36871496)
32. Chiaravalli AM, Feltri M, Bertolini V, et al: Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection. Virchows Arch 448: 344-353, 2006. (Pubitemid 43357652)
33. Lee HE, Chae SW, Lee YJ, Kim MA, Lee HS, Lee BL and Kim WH: Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer 99: 1704-1711, 2008.
34. Geddert H, Zur Hausen A, Gabbert HE and Sarbia M: EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1. Anal Cell Pathol (Amst) 33: 143-149, 2010.
35. Gylling A, Abdel-Rahman WM, Juhola M, et al: Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study. Gut 56: 926-933, 2007. (Pubitemid 46999075)
36. Milne AN, Carneiro F, O'Morain C and Offerhaus GJ: Nature meets nurture: molecular genetics of gastric cancer. Hum Genet 126: 615-628, 2009.
37. Woo DK, Lee WA, Kim YI and Kim WH: Microsatellite instability and alteration of E2F-4 gene in adenosquamous and squamous cell carcinomas of the stomach. Pathol Int 50: 690-695, 2000.
38. Wu M, Semba S, Oue N, Ikehara N, Yasui W and Yokozaki H: BRAF/K-ras mutation, microsatellite instability, and promoter hypermethylation of hMLH1/MGMT in human gastric carcinomas. Gastric Cancer 7: 246-253, 2004.
39. Zhao W, Chan TL, Chu KM, Chan AS, Stratton MR, Yuen ST and Leung SY: Mutations of BRAF and KRAS in gastric cancer and their association with microsatellite instability. Int J Cancer 108: 167-169, 2004. (Pubitemid 37444461)
40. Gu M, Kim D, Bae Y, Choi J, Kim S and Song S: Analysis of microsatellite instability, protein expression and methylation status of hMLH1 and hMSH2 genes in gastric carcinomas. Hepatogastroenterology 56: 899-904, 2009.
41. Li JH, Shi XZ, Liu M, Wang Y, Yu ZH, Xu GW and Lu S: Methylation of hMLH1 gene promoter in gastric carcinoma with microsatellite instability. Ai Zheng 24: 273-277, 2005.
42. Hamelin R, Chalastanis A, Colas C, et al: Clinical and molecular consequences of microsatellite instability in human cancers. Bull Cancer 95: 121-132, 2008. (Pubitemid 351262491)
43. Baiyee D and Banner B: Mismatch repair genes in renal cortical neoplasms. Hum Pathol 37: 185-189, 2006. (Pubitemid 43099838)
44. Diakoumis E, Sourvinos G, Kiaris H, Delakas D, Cranidis A and Spandidos DA: Genetic instability in renal cell carcinoma. Eur Urol 33: 227-232, 1998. (Pubitemid 28073771)
45. Kanomata N, Eble JN and Hailing KC: Microsatellite instability is uncommon in young patients with renal cell carcinoma. Cancer Genet Cytogenet 101: 123-127, 1998. (Pubitemid 28141173)
46. Matsuda H, Uejima S and Kurita T: Microsatellite instability in renal cell carcinoma and bladder tumors. Hinyokika Kiyo 42: 27-31, 1996. (Pubitemid 126511963)
47. Uchida T, Wada C, Wang C, Egawa S, Ohtani H and Koshiba K: Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma. Cancer Res 54: 3682-3685, 1994. (Pubitemid 24241178)
48. Leach FS, Koh M, Sharma K, et al: Mismatch repair gene mutations in renal cell carcinoma. Cancer Biol Ther 1: 530-536, 2002.
49. Cullinane CA, Ellenhorn JD and Weitzel JN: Microsatellite instability is a rare finding in tumors of patients with both primary renal and rectal neoplasms. Cancer Genet Cytogenet 148: 163-165, 2004. (Pubitemid 38083347)
50. Poulogiannis G, Frayling IM and Arends MJ: DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome. Histopathology 56: 167-179, 2010.
51. Seruca R, Velho S, Oliveira C, Leite M, Matos P and Jordan P: Unmasking the role of KRAS and BRAF pathways in MSI colorectal tumors. Expert Rev Gastroenterol Hepatol 3: 5-9, 2009.
52. Oliveira C, Pinto M, Duval A, et al: BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency. Oncogene 22: 9192-9196, 2003. (Pubitemid 38067995)
53. Jiang W, Kahn SM, Guillem JG, Lu SH and Weinstein IB: Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. Oncogene 4: 923-928, 1989. (Pubitemid 19176982)
54. Lee SH, Lee JW, Soung YH, et al: BRAF and KRAS mutations in stomach cancer. Oncogene 22: 6942-6945, 2003. (Pubitemid 37386695)
55. Lee KH, Lee JS, Suh C et al: Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases. Cancer 75: 2794-2801, 1995.
56. Arber N, Shapiral, Ratan J, et al: Activation of c-K-ras mutations in human gastrointestinal tumors. Gastroenterology 118: 1045-1050, 2000. (Pubitemid 30346981)
57. Craanen ME, Blok P, Top B, et al: Absence of ras gene mutations in early gastric carcinomas. Gut 37: 758-762, 1995.
58. Waldmann V and Rabes HM: Proliferative heterogeneity of human renal cell carcinomas and prevalence of ras gene point mutations. J Cancer Res Clin Oncol 122: 207-213, 1996. (Pubitemid 26084669)
59. Van Krieken JH, Jung A, Kirchner T, et al: KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch 453: 417-431, 2008.
60. Brennetot C, Duval A, Hamelin R, Pinto M, Oliveira C, Seruca R and Schwartz S Jr: Frequent Ki-ras mutations in gastric tumors of the MSI phenotype. Gastroenterology 125: 1282, 2003.
61. Pavlovich CP and Schmidt LS: Searching for the hereditary causes of renal-cell carcinoma, Nat Rev Cancer 4: 381-393, 2004. (Pubitemid 38579484)
62. Hansel DE: Genetic alterations and histopathologic findings in familial renal cell carcinoma. Histol Histopathol 21: 437-444, 2006.